Grail Stock Rises With Funding From Samsung to Bring Cancer Detection Test to Asia
By Emon Reiser
Shares for Grail climbed after the biotechnology company said Samsung would invest $110 million to expand its multi-cancer early detection test in Asia.
The stock rose 11%, to $83.85, in midday Thursday trading, putting it on pace for a new 52-week high.
Grail said Samsung Electronics along with South Korean construction and engineering company Samsung Construction & Trading signed a binding letter of intent for the strategic collaboration to bring the healthcare company's Galleri test to key Asian markets, starting with South Korea.
The investment, valued at $70.05 a share with a closing date set for early next year, makes Samsung C&T an exclusive partner to commercialize Grail's cancer detection test. The companies plan further expansion into Japan and Singapore.
Write to Emon Reiser at emon.reiser@wsj.com
(END) Dow Jones Newswires
October 16, 2025 12:02 ET (16:02 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States